# Phylogix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/phylogix

- Industry: Biotechnology
- Headquarters: Waltham, US
- Total disclosed funding: $15M
- Latest round: Series B (Mar 9, 2004)
- Investors on record: 6

## About

Phylogix, based in the US, is a biotechnology company. It engages in developing lectin-based drugs focused on tissue protection, oncology, and immunology.

## Funding rounds

- Series B, Mar 9, 2004, $12M — Atlas Venture, Prospect Venture Partners, Canaan Partners, Radius Ventures, SEAF, BVF Partners
- Series A, Dec 7, 2001, $3M — SEAF, BVF Partners

## Investors

- SEAF (https://capitalatlas.ai/funds/seaf) — Series A, Series B
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series A, Series B
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series B
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series B
- Radius Ventures (https://capitalatlas.ai/funds/radius-ventures) — Series B